Department of Neurosurgery, Henry Ford Hospital, Detroit, Michigan.
Department of Orthopedic Surgery, Beaumont Health, Royal Oak, Michigan.
Neurosurgery. 2020 Jul 1;87(1):142-149. doi: 10.1093/neuros/nyz423.
It is important to delineate the relationship between opioid use and spine surgery outcomes.
To determine the association between preoperative opioid usage and postoperative adverse events, patient satisfaction, return to work, and improvement in Oswestry Disability Index (ODI) in patients undergoing lumbar fusion procedures by using 2-yr data from a prospective spine registry.
Preoperative opioid chronicity from 8693 lumbar fusion patients was defined as opioid-naïve (no usage), new users (<6 wk), short-term users (6 wk-3 mo), intermediate-term users (3-6 mo), and chronic users (>6 mo). Multivariate generalized estimating equation models were constructed.
All comparisons were to opioid-naïve patients. Chronic opioid users showed less satisfaction with their procedure at 90 d (Relative Risk (RR) 0.95, P = .001), 1 yr (RR 0.89, P = .001), and 2 yr (RR 0.89, P = .005). New opioid users were more likely to show improvement in ODI at 90 d (RR 1.25, P < .001), 1 yr (RR 1.17, P < .001), and 2 yr (RR 1.19, P = .002). Short-term opioid users were more likely to show ODI improvement at 90 d (RR 1.25, P < .001). Chronic opioid users were less likely to show ODI improvement at 90 d (RR 0.90, P = .004), 1 yr (RR 0.85, P < .001), and 2 yr (RR 0.80, P = .003). Chronic opioid users were less likely to return to work at 90 d (RR 0.80, P < .001).
In lumbar fusion patients and when compared to opioid-naïve patients, new opioid users were more likely and chronic opioid users less likely to have improved ODI scores 2 yr after surgery. Chronic opioid users are less likely to be satisfied with their procedure 2 yr after surgery and less likely to return to work at 90 d. Preoperative opioid counseling is advised.
明确阿片类药物使用与脊柱手术结果之间的关系非常重要。
通过使用前瞻性脊柱登记处的 2 年数据,确定术前阿片类药物使用与术后不良事件、患者满意度、重返工作岗位以及腰椎融合术后 Oswestry 残疾指数(ODI)改善之间的关系。
8693 例腰椎融合患者的术前阿片类药物慢性使用情况定义为阿片类药物未使用(无使用)、新使用者(<6 周)、短期使用者(6 周-3 个月)、中期使用者(3-6 个月)和慢性使用者(>6 个月)。构建了多变量广义估计方程模型。
所有比较均针对阿片类药物未使用者。慢性阿片类药物使用者在 90 天(相对风险(RR)0.95,P=0.001)、1 年(RR 0.89,P=0.001)和 2 年(RR 0.89,P=0.005)时对手术的满意度较低。新的阿片类药物使用者在 90 天(RR 1.25,P<0.001)、1 年(RR 1.17,P<0.001)和 2 年(RR 1.19,P=0.002)时更有可能改善 ODI。短期阿片类药物使用者在 90 天(RR 1.25,P<0.001)时更有可能改善 ODI。慢性阿片类药物使用者在 90 天(RR 0.90,P=0.004)、1 年(RR 0.85,P<0.001)和 2 年(RR 0.80,P=0.003)时更不可能改善 ODI。慢性阿片类药物使用者在 90 天(RR 0.80,P<0.001)时重返工作岗位的可能性较低。
在腰椎融合患者中,与阿片类药物未使用者相比,新的阿片类药物使用者在手术后 2 年时 ODI 评分更有可能改善,而慢性阿片类药物使用者则不太可能改善。慢性阿片类药物使用者在手术后 2 年时对手术结果的满意度较低,90 天时重返工作岗位的可能性较低。建议在术前进行阿片类药物咨询。